ArticleFrontiers in bioengineering and biotechnology2025
A novel nail-plate construct for the treatment of AO/OTA 31-A3.3 intertrochanteric fractures: a finite element analysis.
Article in Frontiers in bioengineering and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Biomechanical advantages of double-column bridging plate-augmented PFNA for complex subtrochanteric femoral fractures: a finite element analysis.BMC musculoskeletal disorders · 2026Article
- 320 mm InterTan nail optimizes biomechanics in AO/OTA 31A2.3 fractures: superior stress distribution, micromotion, and strain for enhanced healing.Frontiers in bioengineering and biotechnology · 2026Article
- Comparison of proximal femoral universal nail and proximal femoral nail anti-rotation internal fixation for older patients with intertrochanteric femoral fracture: a retrospective cohort study.Frontiers in medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The AO/OTA 31-A3.3 is the most unstable type with a lesser trochanteric fragment and a broken lateral femoral wall (LFW), which constitute a four-part unstable intertrochanteric fracture. Implant failure remains one of the catastrophic consequences after surgical treatment. A novel nail-plate construct, called proximal femoral universal nail system (PFUN), is proposed by our team to fix comminuted LFW fracture fragment and lesser trochanteric fragment. The aim of this study is to evaluate the biomechanical properties of PFUN compared with proximal femoral nails anti-rotation (PFNA) for the treatment of AO/OTA 31-A3.3 intertrochanteric fractures. Methods: An AO/OTA 31-A3.3 intertrochanteric fracture model was established by computed tomography images. The models of implant (PFUN and PFNA) were created and virtually inserted into the A3.3 fracture model. The von Mises stress on the proximal femur, fracture end, implant and the total displacement of the device components were evaluated and compared for both PFUN and PFNA models. Results: The maximum von Mises stress in the proximal femur of the PFNA model increased by 85.81% when compared with the PFUN model in A 3.3 intertrochanteric fractures. The peak von Mises stress was located at the medial-inferior part of the fracture ends in the PFUN and PFNA models and the maximum von Mises stress in the PFUN model and PFNA model was 27.27 MPa and 49.95MPa, respectively. The PFUN model and PFNA model had similar peak von Mises stress in the implant. Furthermore, the maximum displacement in the PFUN model was much smaller than that in the PFNA model. Conclusion: The PFUN exhibited a lower peak von Mises stress in the proximal femur and fracture end, and a smaller maximum model displacement than PFNA in A3.3 intertrochanteric fractures. Our findings might provide valuable references for clinical decision making in surgical treatment of complex intertrochanteric fractures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.